Product Information
FENOFIBRATE 160 MG TABLET is a generic product labeled by Leading Pharma, LLC, priced at $0.1208 per EA under NDC 69315029005. Its NADAC has been published 119 times since Jun 28, 2023.
FDA first approved this application on Aug 17, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
160 mg/1
Manufacturer
Leading Pharma, LLCNDC
69315029005
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/17/2025
Active Ingredients
FENOFIBRATEApproval Type
Generic (ANDA)
FDA Application
ANDA210606FDA Approved
8/17/2018
TE Code
AB
On Market Since
8/20/2022
Pharmacological Classes
Price Statistics
The NADAC for FENOFIBRATE 160 MG TABLET has been published 119 times since Jun 28, 2023, and over the history we have for it it has declined 9.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1208 per EA |
|---|---|
| All-time high | $0.1659 (Aug 16, 2023) |
| All-time low | $0.0950 (May 22, 2024) |
| 52-week high | $0.1255 |
| 52-week low | $0.1208 |
| Median price | $0.1282 |
| Average price | $0.1286 |
| Largest weekly change | +41.1% (Jan 17, 2024) |
| Weeks tracked | 119 |
| Tracking since | Jun 28, 2023 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
-3.8%
3Y
-27.2%
5Y
N/A
All
-9.2%
Last surveyed Oct 1, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 17% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of FENOFIBRATE 160 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FENOFIBRATE 160 MG TABLET, manufactured by Leading Pharma, LLC, is $0.1208 per EA (NDC 69315029005), effective Oct 1, 2025.
How has the price of FENOFIBRATE 160 MG TABLET changed over time?
Over the history we have for it, the NADAC for FENOFIBRATE 160 MG TABLET has declined 9.2%. It has been tracked across 119 weekly CMS publications since Jun 28, 2023.
What are the highest and lowest recorded NADAC prices for FENOFIBRATE 160 MG TABLET?
Since Jun 28, 2023, the NADAC for FENOFIBRATE 160 MG TABLET has ranged from a low of $0.0950 (May 22, 2024) to a high of $0.1659 (Aug 16, 2023), with a median of $0.1282 per EA.
Are there cheaper alternatives to FENOFIBRATE 160 MG TABLET?
Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, FENOFIBRATE 160 MG TABLET, is $0.1008 per EA — about 17% below FENOFIBRATE 160 MG TABLET.
Who manufactures FENOFIBRATE 160 MG TABLET?
FENOFIBRATE 160 MG TABLET (NDC 69315029005) is labeled by Leading Pharma, LLC, and CMS classifies it as a generic product.